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Summary -Monolayer cultures have been established from a poorly differentiated
carcinoma of the lung. Homogeneous cell growth and morphology have been main-
tained for over 18 months through more than 80 subculture passages, and the cells
have been found to produce both immunoreactive calcitonin and an immunoreactive
carcinoembryonic antigen-like material.
THE ASSOCIATION of hormone excess
and tumours of non-endocrine origin
(the so-called ectopic hormone syndromes)
has been documented for a wide range of
peptide hormones (for review, see Rees
and Ratcliffe, 1974). The phenomenon
may be overt and present as a clinical
endocrinopathy where the hormone
involved has obvious metabolic effects,
or be latent and apparent only after
laboratory investigations.
In seeking to understand the signifi-
cance and implications of such hormone
excess, it is important to know whether
the tumour is synthesizing the hormone
in question or in some unknown way
causing increased release of the hormone
from its physiological source.
Recent reports have suggested that the
peptide calcitonin (CT) occurs as an
' ectopic hormone " in association with a
number of tumours (Coombes et al.,
1974; Milhaud et al., 1974). Evidence
obtained by Silva et al. (1.974) ofan arterio-
venous gradient across the tuimour bed
and by Hillyard et al. (1975) of elevated
tumour tissue levels, suggests that the
calcitonin is tumour derived.
We report long-term tissue culture
studies of a humnan cell line (" BEN ")
derived from a poorly differentiated
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epidermoid bronchial carcinoma whose
cells produce material having immuno-
logical and biological properties resembling
calcitonin, together with an immuno -
reactive carcinoembryonic antigen (CEA)-
like material.
Case report
A 71-year old man (who had smoked
30 cigarettes/day for 20 years) presented
with a 3-month history of weight loss, severe
pain in the left hip on movement, cough and
purulent sputum. In addition, he had
complained of thf , polyuria and constipa-
tion for three weeks. Clinical examination
revealed 2 hard 1 cm diameter left-sided
supraclavicular nodes and bilateral corneal
calcification. An upper mediastinal mass
and patchy shadowing in the left upper
lobe, together with a lytic lesion of the left
acetabulum was all that was seen after an
extensive radiographic survey.
Biochemical analysis of the plasma gave
the following results: urea, 125 mg/100 ml;
sodium, 139 mEq/l; potassium, 3-9 mEq/l;
bicarbonate, 20 mEq/l. The serum levels of
calcium were 14-5 mg/100 ml, phosphate,
5*0 mg/100 ml and alkaline phosphate,
92 i.u./l (upper limit of normal, 95 i.u./l).
The supraclavicular nodes were excised
surgicallyandhistologicalexaminationshowed
the presence of an undifferentiated carcinoma
whose appearance was consistent with aM. ELLISON ET AL.
bronchial origin. Cytologically, the sputum
was considered to contain poorly differen-
tiated squamous carcinoma cells.
Treatment of the hypercalcaemia was
initially undertaken using intravenous fluids
and during this time (while the blood urea
level was 76 mg/100 ml) immunoreactive
parathyroid hormone was measured and
found to be 0-25 ng/ml and 0-28 ng/ml on
successive days (normal, less than 0 9 ng/ml,
Addison et al., 1971). Plasma immuno-
reactive calcitonin concentration was
2.58 ng/ml (normal, less than 0.1 ng/ml,
Coombes et al., 1974) and plasma CEA was
23'4 ng/ml (normal, less than 20-0 ng/ml,
Mackay et al., 1974).
The skeletal metastasis was treated by
radiotherapy, and chemotherapy was insti-
tuted using methotrexate and cyclophos-
phamide. There was, however, no clinical,
radiological or biochemical response to treat-
ment and the patient died 3 weeks after
admission. Permission for an autopsy was
refused.
MATERIALS AND METHODS
Monolayer cell cultures were initiated
from a tumour containing part of the supra-
clavicular node by gently rubbing the cut
surface on a stainless steel grid in medium so
that individual cells and small clumps of
tumour tissue fell through. Fibrous tissue
which would not pass the grid was discarded.
Cultures were established and maintained
in 5 ml of medium in plastic flasks (25 cm2
Falcon). The medium .k based on 45%
TC 199 HEPES buffered (Biocult) +45%
Dulbecco's Eagle's bicarbonate buffered
with 10% of either foetal calf serum (Flow
Laboratories) or human plasma, and con-
tained 100 ,ug/ml kanamycin and 2-5 ,ug/ml
amphotericin B. Cultures were gassed with
5% CO2 in air and maintained at 37°C. The
cells were subcultured each week and medium
changed daily for assay of cell products.
Calcitonin and CEA were measured by
radioimmunoassay (Clark et al., 1969;
Laurence et at., 1972; Coombes et al., 1974)
of cell exposed culture medium using fresh
medium ofthe same batch for the preparation
of standard curves.
Using 1251-labelled standard added to
living cell cultures, followed by precipitation
of intact peptide by 10% trichloroacetic
acid, CT was shown to be at least 90% stable
for 24 h. The stability of CEA was checked
by radioimmunoassay of added cold CEA
and was also found to be more than 90%
stable over 24 h in contact with living cells
at 370C.
Biological activity of cell exposed culture
medium was assessed by an in vitro 45Ca-
prelabelled neonatal bone bioassay system
(Powles et al., 1973).
RESULTS
Monolayer culture
Tumour cells readily attached to the
plastic surface and spread to form " epithe-
lioid " islands. Growth with obvious
mitotic activity was apparent from the
start. Fibroblasts accounted for about
5% of the original cells plated but these
were quickly outgrown. Alllymphocytes,
macrophages and other unidentified cell
types appeared to be eliminated com-
pletely after the first subculture.
Cultures have been maintained with
homogeneous growth rate and morphology
for more than 18 months over 80 sub-
culture passages. The average doubling
time has been 3 days with 2-3 doublings
per passage.
Ultrastructural characteristics of the
original biopsy material (Fig. la) have
been retained for at least 25 subculture
passages (Fig. lb).
Calcitonin production
Samples of culture medium after
incubation with these cells consistently
inhibited the binding of 125I-labelled
synthetic human calcitonin-M to anti-
calcitonin antibodyin aradioimmunoassay
as shown in Fig. 2. Although the regres-
sion curves obtained did not parallel the
curves for standard human calcitonin-M,
an estimate of calcitonin equivalents in
the medium was possible and immuno-
reactive CT equivalents so registered
were in excess of 20 times the detection
limits of the assay. Medium from the
primary culture and from subculture
passages 19, 42, 58 and 76 gave values
within the same range. Radioimmuno-
assay ofthe patient's plasma in 6 dilutions
374IMMUNOREACTIVE CALCITONIN PRODUCTION
(a) (b)
FiG. 1.-Electron micrographs of tumour cells. x 52,500. (a) From the original supraclavicular
node biopsy. (b) From monolayer culture in the 25th subculture passage.
gave regression curves which were similar
to those of cell exposed medium, being
also non-parallel with the synthetic CT
standard.
The inhibition of binding due to cell
exposed medium was completely abolished
by prior extraction of the medium with
Spherosil which has been shown to
extract CT from plasma (Coombes et al.,
1974).
Fresh culture medium containing
human plasma showed no CT-like immu-
noreactivity, nor was any detectable in
medium exposed to human fibroblast
monolayer cultures. Medium taken from
monolayer cultures of 2 oat cell carcino-
mata (1 short-term and 1 proliferative
culture) were also positive for immuno-
reactive CT. Three other oat cell carci-
noma cultures gave no inhibition in the
CT immunoassay.
" BEN " cells from the 30th passage
gave a positive reaction for CT by an
immunofluorescence staining technique
using anti-human calcitonin (Pearse and
Polak, 1974). Negative results were
obtained with suitable control procedures,
including anti-serum absorbed withhuman
calcitonin, normal rabbit serum and anti-
calcitonin on control monolayer cultured
cells (J. Polak, personal communication).
Medium samples from " BEN " cells
incubated with prelabelled mouse calvaria
suppressed the release of 45Ca++ as shown
in the Table. From this it can be seen
that material from the cells has an
action similar to human CT in this system
(Reynolds, 1968) although the quantity of
bioactive CT-like material cannot be
estimated without further purification.
TABLE
" BEN " cell
passage
8
11
75
% release by
control bones
39 ± 6
32 ±10-8
31*7± 3 9
% release by
bones + cell
medium
21 ±3
16- 9±2- 1
28-7+1-3
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FIcG. 2. 1251-Calcitonin displacement curves for standard synthetic human calcitonin M (Oj -O)
compared with medium from " BEN" cells (A A, 0 *) and from normal fibroblasts
(A A)-
(CEA production
" BEN " cell cultures were also shown
by radioimmunoassay to produce a CEA-
like material which inhibited binding of
'251-labelled colonic CEA to antibody in
proportions paralleling those of authentic
colonic CEA through the range 500-2 ng/
ml. Figure 3 shows the levels in medium
removed daily from Day 3 in a culture of
the 13th passage, initiated with 1 x 106
cells and multiplying to produce 4'6 x 106
cells by Day 7. Immunoreactive CEA
was detected on the cell surfaces by an
immunoperoxidase technique at the elec-
tron microscope level (Breborowicz et al.,
1975). All the " BEN " cells exposed to
anti-CEA showed a positive reaction
whereas controls using normal serum or
anti-CEA on normal fibroblasts were
negative (M. Birbeck, personal communi-
cation).
In addition, cell exposed medium was
tested for adrenocorticotrophic hormone,
growth hormone, insulin and cx-foeto-
protein. None of these products was
detected.
DISCUSSION
Immunoreactive calcitonin possessing
appropriate biological activity has been
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FIG. 3. Immunoreactive CT (A A) and CEA (0 0) equivalents from a monolayer culture
of " BEN " cells in the 13th passage, initiated with 1 x 106 cells at Day 0 and multiplying to
4-6 x 106 cells by Day 7.
demonstrated in association with cells
from a poorly differentiated carcinoma
of the lung over a period of more than 18
months in monolayer culture. Since these
cells have undergone at least 100 divisions
during this in vitro period while CT levels
have been maintained, it is clear that the
cells have the stable heritable character-
istic of immunoreactive CT synthesis and
release.
Cells of both the original tumour and
subsequent cultures have ultrastructural
characteristics, in particular membrane-
bound, electron-dense granules which are
also present in other CT producing cells
(Braunstein, Stephens and Gibson, 1968;
Kalina and Pearse, 1971). Specific
immunofluorescent staining of "BEN"
cells with anti-human calcitonin serum
also supports the presence of a CT-like
material in the long-term cultured cells.
Calculations based on the number of
cells at each passage and the number of
divisions since explantation indicate that
this CT-like material has been produced
in vitro and cannot be accounted for by a
persistence of CT produced in vivo.
The radioimmunoassay data showing
that the tumour CT-like product does not
compete with 125J-CT in the same way as
does synthetic human CT-monomer sug-
gests that the tumour CT may differ in
molecular form from the normal. This is
supported by preliminary chromato-
graphic investigation (R. C. Coombes, in
preparation) and by reports of immuno-
chemical heterogeneity oftumour CT from
plasma (Deftos et al., 1975).
The demonstration that tumour cells
derived from lung tissue are capable of
a
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immunoreactive-CT production confirms
the inclusion of this hormone within the
para-endocrine syndrome and supports
suggestions (Coombes et al., 1974; Silva
et al., 1974; Hillyard et al., 1975) that in
other cases elevated CT levels in tumour
bearing patients may be due to a tumour
produced hormone.
It is of interest that the patient
reported here had both hypercalcaemia
and hypercalcitoninaemia. In the
absence of tissue culture evidence, it may
have been assumed that the CT was
derivedfrom thethyroidCcells, inresponse
to elevated Ca++ and not from the
tumour.
Further in vitro studies are required
to establish the proportion of tumour
associated hypercalcitoninaemia cases
which are due to hormone production by
the tumour and to examine the tumour-CT
response to a wide variety ofsecretagogues
such as calcium infusions or the ingestion
of alcohol. Such findings could be impor-
tant in assisting tumour diagnosis and
assessing the effectiveness of therapy.
The results shown in Fig. 3 suggest
that the CT production does not bear the
same relationship to cell number as does
the CEA. Itis atpresentnot clearwhether
this reflects a heterogeneous cell popula-
tion or whether individual cells produce
both materials and the rates of synthesis
and release vary in response to different
factors in the environment. The presence
of " endocrine " granules in cells which are
positively stained for CEA at their sur-
faces suggests that single cells can synthe-
size both products, but further studies
involving cloning are being undertaken
to confirm this.
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